Sol-Gel Technologies Hits New 52-Week High of $30.98, Surges 3861%

Sol-Gel Technologies has reached a significant milestone by hitting a new 52-week high of USD 30.98 on September 19, 2025. This achievement marks a remarkable performance for the microcap company, which operates in the Pharmaceuticals & Biotechnology industry. Over the past year, Sol-Gel Technologies has demonstrated an impressive return of 3861.04%, significantly outperforming the S&P 500, which recorded a return of 16.64% during the same period.
The company's financial metrics reflect its growth trajectory, with net sales soaring by 1574.2% to USD 18.29 million in the first half of the year. Despite being in a loss-making position, Sol-Gel's return on capital employed (ROCE) has shown improvement, reaching -10.21%. The stock's price-to-book ratio stands at 2.41, indicating its valuation relative to its assets.

Additionally, Sol-Gel Technologies has a notable institutional ownership of 27.81%, suggesting a level of confidence from larger investors in the company's fundamentals. The stock's journey from a 52-week low of USD 4.01 to its current high underscores its dynamic performance in the market.